Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PORT OF NEW ORLEANS (PORT NOLA) via SQUIRE PATTON BOGGS
2026 · third_quarter · Q3
Outreach and education to support continued port infrastructure investments.
Filing targets: Army, Dept of (Corps of Engineers), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), White House Office
GLOBAL ELECTRONICS ASSOCIATION, FORMERLY KNOWN AND REPORTED AS IPC via SQUIRE PATTON BOGGS
2026 · third_quarter · Q3
Source: Senate LDA
Issues affecting electronics manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
ASCENSUS SPECIALTIES LLC via SQUIRE PATTON BOGGS
2026 · third_quarter · Q3
Impact of regulations on pharmaceutical supply chains.
Impact of trade and tariff policies and regulations on pharmaceutical supply chains.
Impact of regulations on pharmaceutical supply chains.
Impact of regulations on pharmaceutical supply chains.
Impact of regulations on pharmaceutical supply chains.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
AON SERVICE CORPORATION (FKA AON HEWITT) via SQUIRE PATTON BOGGS
2026 · third_quarter · Q3
Lobbying in support of Aons crisis response finance facility in connection with global humanitarian relief and disaster response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
GLOBAL ELECTRONICS ASSOCIATION, FORMERLY KNOWN AND REPORTED AS IPC via SQUIRE PATTON BOGGS
2026 · second_quarter · Q2
Issues affecting electronics manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
ASCENSUS SPECIALTIES LLC via SQUIRE PATTON BOGGS
2026 · second_quarter · Q2
Impact of regulations on pharmaceutical supply chains.
Impact of trade and tariff policies and regulations on pharmaceutical supply chains.
Impact of regulations on pharmaceutical supply chains.
Impact of regulations on pharmaceutical supply chains.
Impact of regulations on pharmaceutical supply chains.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)